Peer-reviewedCC BYBiomedicines
Baclofen for Spasticity in Multiple Sclerosis: A Comprehensive Narrative Review
Related
- Outcomes of Comprehensive Multiple Sclerosis Care: A Pilot Comparison of Intensive, Integrated, and Usual Care Approaches
- Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
- Modulatory Effects of Curcumin on Microglia, B and T Lymphocytes in Multiple Sclerosis: A Comprehensive Review of Findings from In vitro, In vivo and Human Studies
- Botulinum toxin type a within function-oriented management of post-stroke spasticity: a narrative review
- A 35-Year-Old Woman With Multiple Sclerosis and a New Atypical Thalamic Lesion: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.
BibTeX
@article{anon2026baclofen,
title = {{Baclofen for Spasticity in Multiple Sclerosis: A Comprehensive Narrative Review}},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701932},
note = {CC BY},
}
RIS
TY - JOUR
TI - Baclofen for Spasticity in Multiple Sclerosis: A Comprehensive Narrative Review
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701932
SN - 2227-9059
ER -